75% of US-Based Operation Warp Speed Vaccine Trials Overseen by Advarra IRB, IBC
Webinar: October 13
Trust Advarra’s integrated solutions and collaborative approach to make your research altogether better.
Advarra® provides institutional review board (IRB), institutional biosafety committee (IBC) and GxP/HRP research compliance consulting services with unprecedented clarity.
Advarra recently acquired Forte, the market-leading provider of clinical technology solutions including OnCore. Learn more
Our Latest Updates
Discover What’s Happening at Advarra
Advarra Executive James Riddle Receives SRA International’s Best Concurrent Session Award
The Society of Research Administrators International (SRA International) has awarded James Riddle, Advarra VP of Institutional Services, its Best Concurrent Session Award.
Study Startup Success for the New Generation of Genetically Engineered Vaccines
The global COVID-19 pandemic has brought vaccine research to the forefront, and a surge of research involving genetically engineered vaccines is currently taking place. The availability of the viral genome…
Q&A – The New Urgency of Clinical Trials: How Oncology Leads the Evolution
In Advarra’s recent virtual symposium, experts from industry and academia met to discuss how oncology research has influenced agility in clinical trial design, particularly during the COVID-19 pandemic. Panelists talked…